Les Kondejewski
Directeur/Bestuurslid bij Ontario Genomics Institute (Private Equity)
Profiel
Dr. Les Kondejewski is a Director of Research Programs at Ontario Genomics Institute (Private Equity) since April 2013.
Dr. Kondejewski has an extensive background in research and project management, particularly in personalized medicine.
Previously, he held research and program management responsibilities at Caprion Proteomics.
Later, at Diaceutics Inc., he worked with client teams to facilitate the creation of integrated development and commercialization plans for targeted therapies.
Dr. Kondejewski received his BSc from Carleton University and his PhD in biochemistry from Dalhousie University.
Les carried out postdoctoral research and a research fellowship at the Protein Engineering Network of Centres of Excellence at the University of Alberta.
Actieve functies van Les Kondejewski
| Bedrijven | Functie | Begin |
|---|---|---|
Ontario Genomics Institute (Private Equity)
 Ontario Genomics Institute (Private Equity) Investment ManagersFinance Ontario Genomics Institute (Private Equity) is a Venture Capital firm in UK. The firm was founded in 2001. The firm is headquartered in London. | Directeur/Bestuurslid | 01-04-2013 |
Eerdere bekende functies van Les Kondejewski
| Bedrijven | Functie | Einde |
|---|---|---|
| DIACEUTICS PLC | Private Equity Investor | 02-12-2012 |
Caprion Proteomics, Inc.
 Caprion Proteomics, Inc. Medical SpecialtiesHealth Technology Caprion Proteomics, Inc. provides proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. It specializes in proteomics, biomarkers, discovery, validation, services, immune monitoring, flow cytometry and elispot areas. The company was founded by Neil Cashman and Martin LeBlanc in 2000 and is headquartered in Montreal, Canada. | Directeur/Bestuurslid | 02-01-2010 |
CellCarta Biosciences, Inc.
 CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada. | Corporate Officer/Principal | - |
Opleiding van Les Kondejewski
| Carleton University | Undergraduate Degree |
| Dalhousie University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| DIACEUTICS PLC | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
CellCarta Biosciences, Inc.
CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada. | Commercial Services |
Ontario Genomics Institute (Private Equity)
Ontario Genomics Institute (Private Equity) Investment ManagersFinance Ontario Genomics Institute (Private Equity) is a Venture Capital firm in UK. The firm was founded in 2001. The firm is headquartered in London. | Finance |
Caprion Proteomics, Inc.
Caprion Proteomics, Inc. Medical SpecialtiesHealth Technology Caprion Proteomics, Inc. provides proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. It specializes in proteomics, biomarkers, discovery, validation, services, immune monitoring, flow cytometry and elispot areas. The company was founded by Neil Cashman and Martin LeBlanc in 2000 and is headquartered in Montreal, Canada. | Health Technology |
